Trademark: 79322137
Status Date
Tuesday, November 1, 2022
Registration Number
6886608
Registration Date
Tuesday, November 1, 2022
Filing Date
Friday, June 11, 2021
Published for Opposition
Tuesday, August 16, 2022
MABQI -
Original Registrant
40 Custom manufacturing of pharmaceutical products for third parties; these services exclusively in the field of antibody generation
5 Pharmaceutical products for treatment of metabolic diseases, gastroenterological diseases, inflammatory diseases, auto-immune diseases, cancer diseases, neurological diseases and infectious diseases; chemical preparations for medical or pharmaceutical use for treating metabolic diseases, gastroenterological diseases, inflammatory diseases, auto-immune diseases, cancer diseases, neurological diseases and infectious diseases; medical diagnostic preparations; chemical reagents for medical or veterinary use; all these goods exclusively in the field of antibody generation
1 Chemical products for use in industry and science; chemical preparations for scientific use, other than for medical or veterinary use; biological preparations for use in industry and science; chemical reagents other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary use; biological preparations other than for medical or veterinary use; monoclonal antibodies for scientific use; all these goods exclusively in the field of antibody generation
45 Intellectual property licensing; licensing of patents; legal services, namely, copyright and industrial property right licensing; all these services exclusively in the field of antibody generation
44 Advisory services and information services relating to diagnostic and therapeutic properties in the field of pharmaceuticals; information and advisory services in the medical field; medical services; all these services exclusively in the field of antibody generation
42 Research laboratory services; biological research; scientific research; clinical research; biochemical research; biotechnological research services; medical research; research in the field of pharmaceutical products; research and development of new products for third parties; technical research; engineering; technical scientific project study; research scientific project study; all these services exclusively in the field of antibody generation
Mar 21, 2023
Final Decision Transaction Processed By Ib
Feb 23, 2023
Final Disposition Notice Sent To Ib
Feb 23, 2023
Final Disposition Processed
Feb 1, 2023
Final Disposition Notice Created, To Be Sent To Ib
Nov 1, 2022
Notice Of Registration Confirmation Emailed
Nov 1, 2022
Registered-Principal Register
Aug 16, 2022
Notification Processed By Ib
Aug 16, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 16, 2022
Published For Opposition
Jul 27, 2022
Notification Of Possible Opposition Sent To Ib
Jul 27, 2022
Notification Of Notice Of Publication E-Mailed
Jul 27, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 8, 2022
Approved For Pub - Principal Register
Jul 7, 2022
Teas/Email Correspondence Entered
Jul 6, 2022
Correspondence Received In Law Office
Jul 6, 2022
Teas Response To Office Action Received
Jun 6, 2022
Refusal Processed By Ib
May 16, 2022
Non-Final Action Mailed - Refusal Sent To Ib
May 16, 2022
Refusal Processed By Mpu
Apr 1, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Mar 31, 2022
Non-Final Action Written
Mar 2, 2022
Assigned To Examiner
Oct 16, 2021
Application Filing Receipt Mailed
Oct 12, 2021
New Application Office Supplied Data Entered
Oct 8, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
